Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vladislav Belchikov
Observed names:
V. E. Belchikov,
Vladislav E. Belchikov
Institution:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Observed institution:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
ORCID:
0009-0001-7491-6906
Observed ORCID:
0009-0001-7491-6906
OpenAlex ID:
A5094042211
Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration
2024
·
Ekaterina Malakhova
, Dmitriy Pershin
, et al.
·
Cytotherapy
·
17
Haploidentical donor regulatory T cells and memory T cells are safe and effective in children with refractory graft-versus-host disease with concurrent viral infections
2025
·
VictoryIa Vedmedskaia
, Dmitriy Pershin
, et al.
·
Blood
·
1
Experience in developing and scaling a protocol for NK lymphocyte enriched cellular product manufacturing for clinical application
2025
·
Elena A. Kulakovskaya
, Vladislav E. Belchikov
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
1
PDF
Comparative characterization of the cell composition and functional properties of anti-CD19 biomedical cell products manufactured using the CliniMACS Prodigy and G-Rex platforms
2024
·
E. A. Malakhova
, D. E. Pershin
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
1
PDF
Experience in manufacturing a haploidentical biomedical cell product enriched with regulatory T-lymphocytes
2024
·
V. A. Vedmedskaia
, D. E. Pershin
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
PDF
Show more works
View as search
Works count:
5
Citation count:
20
H-index:
1
I10-index:
1
Year
Topic
Type